FOLLOW US

Thyroid Disorders Research Updates

For Medical Professionals

Serum thyroid stimulating hormone autoantibodies (TSAbs) levels are sensitive and specific biomarkers for the diagnosis of Graves’ disease in childhood.
The FDA announced approval of Nexavar® tablets (sorafenib) for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine treatment.
Researchers examined whether thyroid cancer patients treated with radioactive iodine experienced a reduction in swallowing-related quality of life. Read their results.
Researchers examined the correlation between hyperthyroidism and atrial fibrillation in patients admitted to the hospital with new-onset AF.
Graves' disease research summary on remission predictors following anti-thyroid drug treatment.
What is the association between thyroid cancer, breast cancer, and renal cell cancer? A team of researchers explored this question.
close X
SHOW MAIN MENU
SHOW SUB MENU